India's medical tourism sector faces challenges as West Asian tensions continue. Overseas patient numbers remain lower than before the conf...

Brokerages maintain a positive outlook on select large-cap pharmaceutical, automobile, and healthcare stocks, citing strong growth prospect...

Private equity funds are pouring hundreds of millions of dollars into Kerala’s healthcare sector, reshaping a system long dominated by inde...

Benchmark indices experienced a negative close on Thursday, marked by volatile trade and profit booking. Analysts anticipate the Nifty to c...

Max Healthcare Q4FY26 consolidated PAT grew 7% YoY, and revenue increased 12%. Network EBITDA rose 8%. Max Lab and Max@Home saw strong doub...

Indian stock markets are navigating a balance between optimism and caution. Inflationary pressures and global uncertainties are key concern...

A new study shows that over 90% of cancer cases begin with subtle cellular changes before symptoms appear. Scientists now highlight hidden ...

Private hospitals in India are feeling the pinch as government health schemes yield diminishing returns. This downturn provokes a critical ...

For the last five years, the theme on the street has mostly been: Buy today, expect comfort tomorrow. But some of the better wealth-creatin...

Coinbase layoffs 2026: Coinbase has announced job cuts affecting 14% of its staff. CEO Brian Armstrong cited crypto market downturns and th...

In the current phase of market volatility, the only solace to be derived is from market history. And history tells us that, just like good ...

Private equity has boosted India’s healthcare capacity and efficiency, but rising costs and premiums risk limiting access. Strong regulatio...

Max Healthcare Institute Chairman and Managing Director Abhay Soi said the company continued to witness positive trends on all parameters e...

The earnings before interest, tax, depreciation and ammortisation (EBITDA) increased 21% YoY to Rs 497 crore. The EBITDA margin improved 10...

Gross revenue rose 13% to Rs 1,559 crore during Q3FY23 compared to Rs 1,385 crore previous year. On a quarter-on-quarter (QoQ) basis the ne...

Max Healthcare stated that the performance in Q4 was impacted by the Omicron wave with low hospitalisations. However, the Omicron wave impa...

The company saw a decline in Covid-19 related admissions and vaccinations. The volumes dropped significantly during the quarter, it said.